REGENERON PHARMACEUTICALS, INC. - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 6, 2026, for the 2025 Q4 period, REGENERON PHARMACEUTICALS, INC. held in its portfolio 2 assets valued at $33,799,428 (i.e. $33.80M).

The most valuable assets in the portfolio included: Intellia Therapeutics, Inc. ($33.29M), and Adicet Bio, Inc. ($509.50K),

The chart below shows the top 2 valuable assets, and the table below shows the top 2 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in REGENERON PHARMACEUTICALS, INC. Portfolio

Intellia Therapeutics, Inc.

Adicet Bio, Inc.

REGENERON PHARMACEUTICALS, INC. - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
Intellia Therapeutics, Inc.	3702995	33289925	Common Stock
Adicet Bio, Inc.	60511	509503	Common Stock